{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:34:10Z","timestamp":1793144050943,"version":"4.5.0"},"reference-count":25,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Italian Ministry of University and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>In multiple endocrine neoplasia type 2 (MEN2), clinical management of gene carriers (GCs) is still debated, especially in MEN2A. We aimed to evaluate the predictive value of preoperative CTN for medullary thyroid cancer (MTC) diagnosis and excellent response (ER) in MEN2A GCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective evaluation from a prospectively maintained database of 106 GCs who underwent surgery and were followed up at an Italian tertiary referral center from 1993 to 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The most common mutation was RET V804M (36\/106, 34.3%), followed by mutations at the 634 codon (17\/106, 16.2%). Median age at surgery was 39 years. Eighty-six (81.1%) patients had MTC, while 20 patients (18.9%) had C-cell hyperplasia (CCH) alone. Patients with MTC were older than CCH ones both at RET screening and surgery and showed higher preoperative bCTN and sCTN levels. Values of bCTN &amp;gt; 12.60 ng\/L identified MTC patients with a sensitivity of 94.4% and specificity of 74.3%. Incomplete response (IR) was observed in 24\/106 (22.9%) patients during a median follow-up of 6.8 years. Patients with IR had higher preoperative bCTN and sCTN levels than patients with ER. bCTN &amp;lt; 28.25 ng\/L identified patients with ER with a specificity of 95.5% and sensitivity of 76.8%. In multivariate analysis, bCTN &amp;lt; 28.25 ng\/L and the absence of lymph node metastases were independent predictive factors of ER.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GCs with a preoperative bCTN between 12.6 and 28.3 ng\/L have a very high probability of achieving complete biochemical and structural remission after surgery, even when a small intrathyroidal MTC is already present and independently from the RET germline mutation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag041","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:54:06Z","timestamp":1770382446000},"page":"e1785-e1794","source":"Crossref","is-referenced-by-count":2,"title":["Calcitonin thresholds for prediction of medullary thyroid carcinoma and its clinical response in MEN2A gene carriers"],"prefix":"10.1210","volume":"111","author":[{"given":"Alessandro","family":"Prete","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrine Unit 2, University of Pisa , Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4263-4717","authenticated-orcid":false,"given":"Antonio","family":"Matrone","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrine Unit 2, University of Pisa , Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5957-8902","authenticated-orcid":false,"given":"Cristina","family":"Romei","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrine Unit 2, University of Pisa , Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Gambale","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrine Unit 2, University of Pisa , Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Bottici","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrine Unit 2, University of Pisa , Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Casalini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrine Unit 2, University of Pisa , Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liborio","family":"Torregrossa","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical and Molecular Pathology, Pathology Unit 3, University of Pisa , Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Molinaro","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrine Unit 2, University of Pisa , Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Ugolini","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical and Molecular Pathology, Pathology Unit 3, University of Pisa , Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Materazzi","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical and Molecular Pathology and Critical Area, Endocrine Surgery Unit, University of Pisa , Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5333-9257","authenticated-orcid":false,"given":"Rossella","family":"Elisei","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrine Unit 2, University of Pisa , Pisa 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"19","key":"2026061619574321700_dgag041-B1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"issue":"6","key":"2026061619574321700_dgag041-B2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells SA","year":"2015","journal-title":"Thyroid"},{"issue":"4","key":"2026061619574321700_dgag041-B3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/bjs.1800730411","article-title":"Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity","volume":"73","author":"Farndon","year":"1986","journal-title":"Br J Surg"},{"issue":"9","key":"2026061619574321700_dgag041-B4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/genes10090698","article-title":"Twenty-five years experience on RET genetic screening on hereditary MTC: an update on the prevalence of germline RET mutations","volume":"10","author":"Elisei","year":"2019","journal-title":"Genes"},{"issue":"1","key":"2026061619574321700_dgag041-B5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.surg.2022.05.005","article-title":"Medullary thyroid cancer with RET V804M mutation: more indolent than expected?","volume":"173","author":"Frisco","year":"2023","journal-title":"Surgery"},{"issue":"9","key":"2026061619574321700_dgag041-B6","doi-asserted-by":"crossref","first-page":"e734","DOI":"10.1210\/clinem\/dgad156","article-title":"The changing face of multiple endocrine neoplasia 2A: from symptom-based to preventative medicine","volume":"108","author":"Machens","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026061619574321700_dgag041-B7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000346174","article-title":"2012 European Thyroid Association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer","volume":"1","author":"Elisei","year":"2013","journal-title":"Eur Thyroid J"},{"issue":"24","key":"2026061619574321700_dgag041-B8","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.3390\/cancers14246226","article-title":"Prophylactic and early thyroidectomy in RET germline mutation carriers in pediatric and adult population: long-term outcomes of a series of 63 patients","volume":"14","author":"Torresan","year":"2022","journal-title":"Cancers"},{"issue":"21","key":"2026061619574321700_dgag041-B9","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.3390\/cancers13215554","article-title":"Active surveillance in RET gene carriers belonging to families with multiple endocrine neoplasia","volume":"13","author":"Prete","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"2026061619574321700_dgag041-B10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1210\/jcem.85.2.6556","article-title":"Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC)","volume":"85","author":"Cohen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026061619574321700_dgag041-B11","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1210\/jc.2018-02102","article-title":"Fifty years after the first description, MEN 2B syndrome diagnosis is still late: descriptions of two recent cases","volume":"104","author":"Elisei","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026061619574321700_dgag041-B12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/jc.2011-2046","article-title":"The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026061619574321700_dgag041-B13","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1210\/clinem\/dgad061","article-title":"Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment","volume":"108","author":"Prete","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026061619574321700_dgag041-B14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12020-023-03336-4","article-title":"The 5(th) edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma","volume":"80","author":"Basolo","year":"2023","journal-title":"Endocrine"},{"issue":"2","key":"2026061619574321700_dgag041-B15","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2026061619574321700_dgag041-B16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/thy.2014.0277","article-title":"Response to initial therapy predicts clinical outcomes in medullary thyroid cancer","volume":"25","author":"Lindsey","year":"2015","journal-title":"Thyroid"},{"issue":"2","key":"2026061619574321700_dgag041-B17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12020-023-03459-8","article-title":"Clinical presentation of MEN 2A in index vs. non-index patients","volume":"82","author":"Machens","year":"2023","journal-title":"Endocrine"},{"issue":"7","key":"2026061619574321700_dgag041-B18","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1089\/thy.2013.0620","article-title":"Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations","volume":"24","author":"Rich","year":"2014","journal-title":"Thyroid"},{"issue":"9","key":"2026061619574321700_dgag041-B19","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1089\/thy.2015.0673","article-title":"A nationwide study of multiple endocrine neoplasia type 2A in Norway: predictive and prognostic factors for the clinical course of medullary thyroid carcinoma","volume":"26","author":"Opsahl","year":"2016","journal-title":"Thyroid"},{"issue":"3","key":"2026061619574321700_dgag041-B20","doi-asserted-by":"crossref","first-page":"E509","DOI":"10.1210\/jc.2010-1234","article-title":"Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs endocrines","volume":"96","author":"Rohmer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026061619574321700_dgag041-B21","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1210\/jc.2019-00516","article-title":"Long-term outcomes and aggressiveness of hereditary medullary thyroid carcinoma: 40 years of experience at one center","volume":"104","author":"Raue","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061619574321700_dgag041-B22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-3-031-80396-3_11","article-title":"Long-term follow-up in medullary thyroid carcinoma patients","volume":"223","author":"Raue","year":"2025","journal-title":"Recent Results Cancer Res"},{"issue":"8","key":"2026061619574321700_dgag041-B23","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2017-00317","article-title":"Medullary thyroid carcinoma in MEN2A: ATA moderate- or high-risk RET mutations do not predict disease aggressiveness","volume":"102","author":"Voss","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061619574321700_dgag041-B24","doi-asserted-by":"crossref","first-page":"120603","DOI":"10.1016\/j.cca.2025.120603","article-title":"Insights into the stability of serum calcitonin and a comparison of three serum calcitonin immunoassays","volume":"579","author":"Mater","year":"2026","journal-title":"Clin Chim Acta"},{"key":"2026061619574321700_dgag041-B25","doi-asserted-by":"crossref","first-page":"1306232","DOI":"10.3389\/fendo.2023.1306232","article-title":"Global scientific trends on thyroid disease in early 21st century: a bibliometric and visualized analysis","volume":"14","author":"Song","year":"2023","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag041\/66901487\/dgag041.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/7\/e1785\/66901487\/dgag041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/7\/e1785\/66901487\/dgag041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:57:51Z","timestamp":1781654271000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/7\/e1785\/8483855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,2,16]]},"published-print":{"date-parts":[[2026,6,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag041","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,2,16]]}}}